HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2009 update on the classification of renal epithelial tumors in adults.

Abstract
The classification of kidney tumors in adults expands rapidly with new categories recently incorporated. This will result in the modification of the current 2004 World Health Organization (WHO) classification of the adult renal epithelial neoplasms. Emphasis should be placed in defining risk groups categorized as malignant or benign tumors, including a category of tumors with low malignant potential to accommodate recently recognized categories with extremely good prognosis after surgery. Unusual tumors such as familial renal cell carcinoma (RCC), translocation RCC, renal cell carcinoma after neuroblastoma, tubular mucinous and spindle cell carcinoma, and mixed epithelial and stromal tumors are also presented. A number of recently described entities and morphologic variants of classical categories deserve recognition since they can be important in differential diagnosis. This review emphasizes clinical, pathological and genetic features defining renal epithelial tumors in adults.
AuthorsAntonio Lopez-Beltran, Jose C Carrasco, Liang Cheng, Marina Scarpelli, Ziya Kirkali, Rodolfo Montironi
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 16 Issue 5 Pg. 432-43 (May 2009) ISSN: 1442-2042 [Electronic] Australia
PMID19453547 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Adult
  • Humans
  • Kidney Neoplasms (classification, genetics, pathology)
  • Neoplasms, Glandular and Epithelial (classification, genetics, pathology)
  • World Health Organization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: